Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:946-947

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faxon, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faxon, D. P.
Related Collections
Right arrow Restenosis
Right arrow Restenosis
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC

(Circulation. 2000;101:946.)
© 2000 American Heart Association, Inc.


Editorial

Predicting Restenosis

Bigger Is Better but Not Best

David P. Faxon, MD

From the University of Southern California Keck School of Medicine, Los Angeles, Calif.

Correspondence to David P. Faxon, MD, Professor of Medicine, Chief, Division of Cardiology, University of Southern California Keck School of Medicine, 1355 San Pablo St, Suite 117, Los Angeles, CA 90033. E-mail dfaxon@hsc.usc.edu


Key Words: Editorials • restenosis • angioplasty • prognosis • coronary blood flow

The ability to accurately predict restenosis after angioplasty continues to be elusive, despite two decades of clinical and angiographic studies. Although these studies have shown that a number of clinical, procedural, and angiographic factors are related to recurrence of the stenosis, the overall predictive value of these factors remains low.1 Angiographic factors have been most extensively studied and variable, such as ostial lesion location, proximal lesion location, left anterior descending artery lesion location, bifurcation lesion, eccentric lesion, and long lesion, and those vessels receiving collaterals have been shown to have a higher rate of restenosis as well. Perhaps one of the most important advances in our understanding of restenosis has been the relationship between the final minimal lumen diameter (MLD), or residual stenosis, and the likelihood of developing restenosis. Often termed "bigger is better," the inverse relationship between final MLD or percent stenosis and restenosis has been widely studied and well validated.2 The principal of obtaining the largest possible luminal opening during the procedure is now the primary goal of all angioplasty procedures and is the major explanation for why stents reduce restenosis and why their use has become so popular. Even in very large databases, MLD correctly predicted the occurrence of restenosis in only 30% of patients. The price paid for a bigger lumen, however, is more renarrowing, due to unfavorable remodeling and exaggerated intimal hyperplasia. Fortunately, Mother Nature has been kind and, in the clinical setting, only renarrows the artery to roughly half the initial gain in lumen . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. E. Ajani, R. Waksman, D.-H. Cha, L. Gruberg, L. F. Satler, A. D. Pichard, and K. M. Kent
The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation
J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1290 - 1296.
[Abstract] [Full Text] [PDF]